Ruptura aneuryzmatu nekoronárního Valsalvova sinu jako příčina pravostranné kardiální dekompenzace

Pavla Čadová, Josef Veselka(Universitat Autònoma de Barcelona), David Zemánek, Theodor Adla, Jiří Vejvoda(University Hospital in Motol)

Intervenční a akutní kardiologie

March 1, 2013

Cited by 0

Related Papers

Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

|The Lancet|2020|1.2k

Effect of Intra-arrest Transport, Extracorporeal Cardiopulmonary Resuscitation, and Immediate Invasive Assessment and Treatment on Functional Neurologic Outcome in Refractory Out-of-Hospital Cardiac Arrest

|JAMA|2022|674

Long‐term health outcome and mortality evaluation after invasive coronary treatment using drug eluting stents with or without the IVUS guidance. Randomized control trial. HOME DES IVUS

|Catheterization and Cardiovascular Interventions|2009|190

Long-term survival after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a comparison with general population

|European Heart Journal|2014|106

A FTO variant and risk of acute coronary syndrome

|Clinica Chimica Acta|2010|65